Skip to content

Random test of Artificial pancreas machine in cardiovascular surgery field

Random test of Artificial pancreas machine in cardiovascular surgery field - Random test of Artificial pancreas machine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036310
Enrollment
70
Registered
2019-04-01
Start date
2019-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular surgery disease

Interventions

Strict Group: By using Artificial Pancreas Machine, Blood glucose is controlled between 90 - 100 mg/dL. Period: From anesthetic induction to 2POD. Mild Group: By using Artificial Pancreas Machine, B

Sponsors

Toho University Sakura Medical Center, Department of Cardiovascular Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All cardiovascular surgery patients of our Department, except emergent cases.

Exclusion criteria

Exclusion criteria: Emergent cases.

Design outcomes

Primary

MeasureTime frame
Morbidity of major complications, rate of surgical site infection, blood sample tests, higher brain function, delirium

Countries

Japan

Contacts

Public ContactNoboru Motomura

Toho University Sakura Medical Center Department of Cardiovascular Surgery

noboru@motomura.org043-462-8811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026